In addition, we also observed that FOXA1 expression was higher in relative worse tumor stages in ACC, KIRC, KIRP, BRCA, and THCA (Figures 2(a)–2(e)) while lower in ESCA, BLCA, COAD, and READ (Figures 2(f)–2(i)). This evidence concerns the gene FOXA1 and adrenal cortex carcinoma.